PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 18, 2025Journal of Clinical Medicine3 citationsOpen Access

Long-Term Real-World Outcomes of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy up to 108 Weeks

NRNosheen RezaADAnandkumar DubeyNMNadim Mahmud

Key Points

Key points are not available for this paper at this time.

Abstract

: In this large single-center real-world experience of mavacamten therapy, mavacamten was highly effective and maintained an acceptable safety profile, comparable to the clinical trial long-term extension experience.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Reza et al. (2025) studied this question.

synapsesocial.com/papers/6a0268f7f0e0092a97023277https://doi.org/10.3390/jcm14228181
Ask AI
Helpful
Bookmark
Share
View Full Paper